Search research articles
Contact Us
Filters
Showing results (71-80 of 161) with videos related to
Page
of 17
Sort By:
Leukemia
|
May 11, 2024
Context-dependent role of trisomy 6 in myelodysplastic neoplasms and acute myeloid leukemia: a multi-omics analysis
Hussein Awada, Arda Durmaz, Tariq Kewan, et al.
Journal of Comparative Effectiveness Research
|
June 29, 2026
Healthcare resource utilization and costs in patients with multiple myeloma administered ciltacabtagene autoleucel in outpatient versus inpatient settings after one to three prior lines of therapy
Murali Janakiram, Sabyasachi Ghosh, Victoria Alegria, et al.
Human Brain Mapping
|
January 18, 2018
Test-retest reliability and longitudinal analysis of automated hippocampal subregion volumes in healthy ageing and Alzheimer's disease populations
Amanda Worker, Danai Dima, Anna Combes, et al.
Cancer Medicine
|
July 20, 2024
Real-world outcomes of patients with resected stage III melanoma treated with adjuvant therapies
Danai Dima, Nerea Lopetegui-Lia, Olisaemeka Ogbue, et al.
British Journal of Haematology
|
January 6, 2023
External validation of the SAVED score for venous thromboembolism risk stratification in patients with multiple myeloma receiving immunomodulatory drugs
Danai Dima, Ang Li, Lauren M Granat, et al.
Bone Marrow Transplantation
|
February 24, 2023
On demand plerixafor is safe and effective for hematopoietic progenitor cell mobilization in patients with light chain amyloidosis at risk for mobilization failure with G-CSF alone
Anne Hubben, Danai Dima, Tahani Atieh, et al.
Transplantation and Cellular Therapy
|
December 24, 2023
Impact of Frailty on Outcomes after Chimeric Antigen Receptor T Cell Therapy for Patients with Relapsed/Refractory Multiple Myeloma
James A Davis, Danai Dima, Nausheen Ahmed, et al.
European Journal of Haematology
|
February 21, 2024
Efficacy and safety of daratumumab, pomalidomide, and dexamethasone versus daratumumab, carfilzomib, and dexamethasone in daratumumab-naïve relapsed multiple myeloma
Danai Dima, Razan Mansour, James A Davis, et al.
Journal of Internal Medicine
|
November 13, 2023
Splenectomy outcomes in immune cytopenias: Treatment outcomes and determinants of response
Olisaemeka D Ogbue, Waled Bahaj, Tariq Kewan, et al.
Psychiatric Genetics
|
June 18, 2016
Gene-expression analysis of clozapine treatment in whole blood of patients with psychosis
Rebecca N S Harrison, Robin M Murray, Sang Hyuck Lee, et al.
Page
of 17
Search research articles
Search
Showing results (71-80 of 161) with videos related to
Sort By:
Page
of 17
Leukemia
|
May 11, 2024
Context-dependent role of trisomy 6 in myelodysplastic neoplasms and acute myeloid leukemia: a multi-omics analysis
Hussein Awada, Arda Durmaz, Tariq Kewan, et al.
Journal of Comparative Effectiveness Research
|
June 29, 2026
Healthcare resource utilization and costs in patients with multiple myeloma administered ciltacabtagene autoleucel in outpatient versus inpatient settings after one to three prior lines of therapy
Murali Janakiram, Sabyasachi Ghosh, Victoria Alegria, et al.
Human Brain Mapping
|
January 18, 2018
Test-retest reliability and longitudinal analysis of automated hippocampal subregion volumes in healthy ageing and Alzheimer's disease populations
Amanda Worker, Danai Dima, Anna Combes, et al.
Cancer Medicine
|
July 20, 2024
Real-world outcomes of patients with resected stage III melanoma treated with adjuvant therapies
Danai Dima, Nerea Lopetegui-Lia, Olisaemeka Ogbue, et al.
British Journal of Haematology
|
January 6, 2023
External validation of the SAVED score for venous thromboembolism risk stratification in patients with multiple myeloma receiving immunomodulatory drugs
Danai Dima, Ang Li, Lauren M Granat, et al.
Bone Marrow Transplantation
|
February 24, 2023
On demand plerixafor is safe and effective for hematopoietic progenitor cell mobilization in patients with light chain amyloidosis at risk for mobilization failure with G-CSF alone
Anne Hubben, Danai Dima, Tahani Atieh, et al.
Transplantation and Cellular Therapy
|
December 24, 2023
Impact of Frailty on Outcomes after Chimeric Antigen Receptor T Cell Therapy for Patients with Relapsed/Refractory Multiple Myeloma
James A Davis, Danai Dima, Nausheen Ahmed, et al.
European Journal of Haematology
|
February 21, 2024
Efficacy and safety of daratumumab, pomalidomide, and dexamethasone versus daratumumab, carfilzomib, and dexamethasone in daratumumab-naïve relapsed multiple myeloma
Danai Dima, Razan Mansour, James A Davis, et al.
Journal of Internal Medicine
|
November 13, 2023
Splenectomy outcomes in immune cytopenias: Treatment outcomes and determinants of response
Olisaemeka D Ogbue, Waled Bahaj, Tariq Kewan, et al.
Psychiatric Genetics
|
June 18, 2016
Gene-expression analysis of clozapine treatment in whole blood of patients with psychosis
Rebecca N S Harrison, Robin M Murray, Sang Hyuck Lee, et al.
Page
of 17